The nurse is preparing to administer an oral medication and wants to ensure a rapid drug action. Which form of the medication will the nurse administer?

a) While men and women may metabolize drugs differently, this is not the primary reason why women are often excluded from Phase I drug trials.

b) Women are not necessarily more prone to adverse effects, but concerns about fetal exposure and reproductive risks have historically limited women's participation in early trials.

c) This statement is incorrect and misleading. Drug trials are not based on strength but rather on safety, ethical concerns, and risk of reproductive harm.

d) Phase I studies test drugs on healthy volunteers, and historically, women of childbearing age were excluded due to concerns about potential teratogenic effects and unknown risks to a developing fetus. Although regulations have changed, caution is still exercised when including women in early-stage drug trials.

a) While knowing if the patient takes generic medications is useful, it is not the priority. Generic and brand-name drugs generally have the same active ingredients and effects.

b) Orphan drugs are used to treat rare diseases, but this is not a primary concern for most patients and does not directly impact medication safety in routine assessments.

c) Asking about medication safety during pregnancy is important if the patient is pregnant or could become pregnant, but it is not the primary concern for all patients.

d) Over-the-counter (OTC) medications can interact with prescribed medications, potentially leading to adverse effects or reduced efficacy. It is crucial to assess OTC use to ensure there are no dangerous drug interactions.